✦ LIBER ✦

Reirradiation of recurrent head and neck cancers

✍ Scribed by B. Emami; V.R. Devineni; M.A. Hederman; M. Bignardi; G. J. Spector

Book ID: 115042491
Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 342 KB
Volume: 97
Category: Article
ISSN: 0023-852X
DOI: 10.1288/00005537-198701000-00016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reirradiation of recurrent head and neck

Reirradiation of recurrent head and neck cancers with curative intent

✍ Steven J. Chmura; Michael T. Milano; Daniel J. Haraf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Treatment of recurrent head and neck can

Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation

✍ Burkhard Weppelmann; Richard H Wheeler; Glenn E Peters; Robert Y Kim; Sharon A S 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 799 KB

Phase 1 trial of concurrent erlotinib, c

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

✍ Johnny Kao; Eric M. Genden; Chien-Ting Chen; Michael Rivera; Charles C. L. Tong; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

Phase 1 trial of combined chemotherapy a

Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer

✍ Sharon Spencer; Richard Wheeler; Glenn Peters; Ruby Meredith; Sam Beenken; Lisle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract ## Background. The management of recurrent unresectable head and neck cancer remains a challenging problem. Based on the circadian rhythm concept, we sought to determine the maximum tolerated dose (MTD) of infusional 5‐flourouracil (5‐FU), hydroxyurea (HU), and reirradiation (RT). ##

Efficacy and toxicity of reirradiation u

Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer

✍ David J. Sher; Robert I. Haddad; Charles M. Norris Jr; Marshall R. Posner; Lori 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## BACKGROUND: Patients with locally recurrent squamous cell cancer of the head and neck (SCCHN) are reported to have a poor prognosis and limited therapeutic options. Optimal management is selectively applied and morbid. Both surgical resection and chemoradiotherapy are reported to re

Toxicity and survival outcomes of hyperf

Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers

✍ John M. Watkins; Keisuke S. Shirai; Amy E. Wahlquist; Robert K. Stuart; Uzair B. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract ## __Background__. Reirradiation of locoregionally recurrent, previously irradiated head/neck cancer may be considered in situations of unresectability, medical inoperability, or adverse pathologic features found at salvage resection. ## __Methods__. Retrospective cohort analysis of